May 15th 2024
Dennis Petragnani has battled gastrointestinal issues for years, and he shares what he sees as the transformation of change in the public and medical community talking about C diff and therapies around it, and the kinship with people he has met through the Peggy Lillis Foundation.
How Did COVID-19 Affect Clostridioides Difficile Testing and Incidence Rates?
June 1st 2021During the COVID-19 surge last year, the federal government stopped the required reporting on healthcare-associated infections (HAI) thus leaving an absence of data and important information on HAI. One study examined the effect the initial pandemic surge had on Clostridioides Difficile infection (CDI) in one hospital.
Watch
Hospital-Associated SAB, CDI More Than Twice as Likely Among Cancer Patients
May 2nd 2021Cancer patients are more than twice as likely to acquire hospital-associated Staphylococcus aureus bacteraemia (HA-SAB) and Clostridioides difficile infection (HA-CDI) than others, a new study from Australia found.
Read More
Improved Testing and Treatment Strategies for C. Difficile Offered in New Review
April 3rd 2021Clostridium difficile infection (CDI) is a leading cause of healthcare-associated infections and the clinical spectrum ranges from asymptomatic colonization to toxic megacolon and fulminant colitis.
Read More
Visitor Contact Precautions Had Little Effect on C Diff Infections in Simulation Study
April 2nd 2021Infection control efforts to combat hospital-onset Clostridioides difficile infection may be better spent on health care workers’ hand hygiene compliance and environmental cleaning than on visitor contact precautions, a new study suggests.
Read More